NUVARING etonogestrel 11.7mg and ethinylestradiol 2.7mg vaginal drug delivery system Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

nuvaring etonogestrel 11.7mg and ethinylestradiol 2.7mg vaginal drug delivery system

organon pharma pty ltd - ethinylestradiol, quantity: 2.7 mg; etonogestrel, quantity: 11.7 mg - drug delivery system, vaginal - excipient ingredients: magnesium stearate; octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate; isododecane; ethylene/vinyl acetate copolymer; ethylene distearamide - nuvaring is for use for contraception.

TRIFEME ethinylestradiol/levonorgestrel tablet blister pack Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

trifeme ethinylestradiol/levonorgestrel tablet blister pack

pfizer australia pty ltd - ethinylestradiol, quantity: 0.03 mg; levonorgestrel, quantity: 0.125 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; glycol montanate; sucrose; povidone; titanium dioxide; iron oxide yellow; calcium carbonate; glycerol; purified talc; macrogol 6000 - indicated for the prevention of pregnancy.

LOETTE ethinylestradiol / levonorgestrel tablet blister pack Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

loette ethinylestradiol / levonorgestrel tablet blister pack

pfizer australia pty ltd - ethinylestradiol, quantity: 20 microgram; levonorgestrel, quantity: 100 microgram - tablet, film coated - excipient ingredients: lactose monohydrate; macrogol 1500; magnesium stearate; microcrystalline cellulose; glycol montanate; polacrilin potassium; titanium dioxide; hypromellose; hyprolose; macrogol 400 - 1. the prevention of pregnancy. 2. the treatment of moderate acne vulgaris not controlled with topical preparations in post-menarchal, pre-menopausal women who accept contraception.